furosemide nebulization efficacy in acute reactive airway disease

Comparison of the efficacy of Nebulized Salbutamol and Furosemide versus Salbutamol alone on Clinical Severity and Peak Expiratory Flow Rate in Acute Reactive Airway Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201201272782N2

Enrollment

Registered

2013-08-18

Start date

2012-04-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Reactive Airway Disease. chronic obstructive pulmonary disease

Interventions

Intervention 1: Intervention:nebulization of 5 mg salbutamol and 40 mg furesmide for 15 minutes. Intervention 2: Control:nebulization of 5 mg salbutamol and 2 cc sterile water for 15 minutes.

Treatment - Drugs

Intervention:nebulization of 5 mg salbutamol and 40 mg furesmide for 15 minutes.

Control:nebulization of 5 mg salbutamol and 2 cc sterile water for 15 minutes

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:Patients 18-55 years old with clinical manifestation of acute recative airway disease presenting in emergency department Exclsion criteria:Onset of symptoms more than 10 hours;smoking more than 10 pack/year; associated acute medical problem; pregnancy; nebulization with B-agonist during last hours.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Acute Reactive Airway Didease Severity. Timepoint: Before and 45 minutes after intervention. Method of measurement: American Thoracic Society definition.;Peak Expiratory Flow Rate. Timepoint: Before and 15,30 nd 45 minutes after intervention. Method of measurement: Peak flow meter.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKambiz Masoumi

Ahvaz Jundishapur University of Medical Science

kami_masoumi@yahoo.com+98 61 1222 9166

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026